SE400771B - PROCEDURE FOR PREPARING 3ALFA-HYDROXI- AND 3ALFA-HYDROXI-19-NORPREGNANER - Google Patents

PROCEDURE FOR PREPARING 3ALFA-HYDROXI- AND 3ALFA-HYDROXI-19-NORPREGNANER

Info

Publication number
SE400771B
SE400771B SE7306330A SE7306330A SE400771B SE 400771 B SE400771 B SE 400771B SE 7306330 A SE7306330 A SE 7306330A SE 7306330 A SE7306330 A SE 7306330A SE 400771 B SE400771 B SE 400771B
Authority
SE
Sweden
Prior art keywords
3alfa
hydroxi
norpregnaner
preparing
procedure
Prior art date
Application number
SE7306330A
Other languages
Swedish (sv)
Inventor
G H Phillipps
R Lawrence
C E Newall
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of SE400771B publication Critical patent/SE400771B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
SE7306330A 1972-05-05 1973-05-04 PROCEDURE FOR PREPARING 3ALFA-HYDROXI- AND 3ALFA-HYDROXI-19-NORPREGNANER SE400771B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
SE400771B true SE400771B (en) 1978-04-10

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7306330A SE400771B (en) 1972-05-05 1973-05-04 PROCEDURE FOR PREPARING 3ALFA-HYDROXI- AND 3ALFA-HYDROXI-19-NORPREGNANER

Country Status (16)

Country Link
JP (1) JPS4961150A (en)
AT (1) AT355232B (en)
AU (1) AU475168B2 (en)
BE (1) BE799102A (en)
CA (1) CA1013341A (en)
CH (1) CH617710A5 (en)
DE (1) DE2322532A1 (en)
ES (1) ES414411A1 (en)
FR (1) FR2183792B1 (en)
GB (1) GB1430942A (en)
IE (1) IE37596B1 (en)
IL (1) IL42196A (en)
LU (1) LU67546A1 (en)
NL (1) NL7306234A (en)
SE (1) SE400771B (en)
ZA (1) ZA733035B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5939545A (en) * 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
WO1995021617A1 (en) * 1994-02-14 1995-08-17 Cocensys, Inc. Androstanes and pregnanes for allosteric modulation of gaba receptor
GR1003861B (en) * 2000-12-29 2002-04-11 Novel gabaa modulating neurosteroids
JP4915427B2 (en) * 2009-03-30 2012-04-11 ブラザー工業株式会社 Liquid supply joint, liquid discharge head and recording apparatus using the same
WO2013056181A1 (en) 2011-10-14 2013-04-18 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
WO2013112605A2 (en) 2012-01-23 2013-08-01 Sage Therapeutics, Inc. Neuroactive steroid formulations and methods of treating cns disorders
SG11201501911RA (en) 2012-08-21 2015-04-29 Sage Therapeutics Inc Methods of treating epilepsy or status epilepticus
CN105246909B (en) 2013-04-17 2020-10-13 萨奇治疗股份有限公司 19-nor steroids that stimulate neural activity and methods of use thereof
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
KR20230172622A (en) 2013-04-17 2023-12-22 세이지 테라퓨틱스, 인크. 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
WO2015010054A2 (en) 2013-07-19 2015-01-22 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PT3035940T (en) 2013-08-23 2019-01-28 Sage Therapeutics Inc Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (en) 2014-09-08 2017-06-16 Sage Therapeutics Inc Neuroactive steroids, compositions, and uses thereof
CN112940066A (en) 2014-10-16 2021-06-11 萨奇治疗股份有限公司 Compositions and methods for targeting CNS disorders
SI3206493T1 (en) 2014-10-16 2020-10-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
ME03749B (en) 2014-11-27 2021-04-20 Sage Therapeutics Inc Compositions and methods for treating cns disorders
DK3250210T3 (en) 2015-01-26 2021-03-08 Sage Therapeutics Inc COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
DK3258939T3 (en) 2015-02-20 2022-12-12 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF
TW202400182A (en) 2016-03-08 2024-01-01 美商賽吉醫療公司 Neuroactive steroids, compositions, and uses thereof claim of priority
IL309259A (en) 2016-07-11 2024-02-01 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
EP4406602A2 (en) 2016-07-11 2024-07-31 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
PE20230244A1 (en) 2019-05-31 2023-02-07 Sage Therapeutics Inc NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (en) * 1962-09-14 1963-12-20 Roussel Uclaf New process for the preparation of 21-amino steroids
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
IL42196A (en) 1978-10-31
IE37596L (en) 1973-11-05
BE799102A (en) 1973-11-05
FR2183792B1 (en) 1977-07-15
ZA733035B (en) 1974-04-24
FR2183792A1 (en) 1973-12-21
IE37596B1 (en) 1977-08-31
CA1013341A (en) 1977-07-05
ES414411A1 (en) 1976-02-01
AT355232B (en) 1980-02-25
AU475168B2 (en) 1976-08-12
NL7306234A (en) 1973-11-07
ATA395173A (en) 1979-07-15
IL42196A0 (en) 1973-07-30
DE2322532A1 (en) 1973-11-22
CH617710A5 (en) 1980-06-13
GB1430942A (en) 1976-04-07
LU67546A1 (en) 1973-07-13
AU5528473A (en) 1974-11-07
JPS4961150A (en) 1974-06-13

Similar Documents

Publication Publication Date Title
SE404019B (en) PROCEDURE FOR MAKING N-PHOSPHONOMETHYLGLYCIN
SE395366B (en) PROCEDURE FOR PREPARING POROSA TABLETS
SE400771B (en) PROCEDURE FOR PREPARING 3ALFA-HYDROXI- AND 3ALFA-HYDROXI-19-NORPREGNANER
SE413246B (en) PROCEDURE FOR PREPARING CHOLESTEROLOXIDAS
SE415261B (en) PROCEDURE FOR PREPARING POLYPEPTIDES
SE417968B (en) PROCEDURE FOR PENAME DERIVATIVES
SE419339B (en) PROCEDURE FOR PREPARING SUBSTITUTED SULPHONYLACETAMIDOCEPHALOSPORINES
SE397530B (en) PROCEDURE FOR PREPARING 1-PYRAZOLYLALKYL-4-ARYLPIPERAZINE DERIVATIVES
NO140828C (en) PROCEDURE FOR PREPARING PULLULAN
NO139124C (en) PROCEDURE FOR PREPARING ESTERES
SE423540B (en) PROCEDURE FOR PREPARING CERTAIN 13-TIAPROSTAGLANDINES
SE7611202L (en) PROCEDURE FOR PREPARING PYRAZOLODIAZEPINE COMPOUNDS
FI55626B (en) PROCEDURE FOR FRAMSTAELLNING AV EN BEHAOLLARE
NO139130C (en) PROCEDURE FOR PREPARING 2-ALKYLAMINO-DIHYDROPYRIDINES
SE415146B (en) PROCEDURE FOR PREPARING EPAXIDATION CATALYST
SE387344B (en) PROCEDURE FOR PREPARING PYRAZIN-4-OXIDE DERIVATIVES
SE385581B (en) PROCEDURE FOR PREPARING PREFERRED N-METHYLOLKARBAMIDE COMPOUNDS
IT999554B (en) PROCEDURE FOR PREPARING DIACETOSSIBUTANE
SE402454B (en) PROCEDURE FOR PREPARING 2-ALCOXY-5-ALKYL SULPHONYL-TOLUENE
SE384027B (en) PROCEDURE FOR PREPARING NEW ALFA-ALKYL SULFOBENSYL PENICILLINES
RO65197A (en) PROCEDURE FOR PREPARING PENICILINE
IT1033071B (en) PROCEDURE FOR PREPARING THIAZOLSULPHENAMIDES
SE404361B (en) PROCEDURE FOR PREPARING NEW 1-PHENYL-3HYDROXY-3-METHYL-TRIAZENES
SE419441B (en) PROCEDURE FOR PREPARING BUTYROPHENON DERIVATIVES
SE415974B (en) PROCEDURE FOR PREPARING 2-BENZOYL-3-AMINO-PYRIDINE DERIVATIVE